Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone duration trial in children with steroid-sensitive nephrotic syndrome
NL-OMON27512Active, not recruiting
- Sponsor
- Nierstichting
- Start
- Jan 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Idiopathic nephrotic syndrome (INS) and nephrosis comparing 24-week prednisolone with 12-week prednisolone plus placebo extension (2 arms). Primary endpoint: Number of patients with frequent relapses. Started Jan 2005; status: active, not recruiting.
02
Drugs
prednisolone
03
Conditions
Idiopathic nephrotic syndrome (INS)nephrosis
Beyond the preview
Go deeper on NL-OMON27512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27512.